18 18 Jaber S, Chanques G, Sebbane M, et al. Noninvasive positive pressure ventilation in patients with respiratory failure due to severe acute pancreatitis. Respiration 2006; 73(2):166–172.
19 19 Wu X, Zheng R, Lin H, et al. [Effect of transpulmonary pressure‐directed mechanical ventilation on respiration in severe acute pancreatitis patient with intraabdominal hypertension]. Zhonghua Yi Xue Za Zhi 2015; 95(39):3168–3172.
20 20 Thandassery RB, Choudhary N, Bahl A, Kochhar R. Characterization of cardiac dysfunction by echocardiography in early severe acute pancreatitis. Pancreas 2017; 46(5):626–630.
21 21 Prasada R, Dhaka N, Bahl A, et al. Prevalence of cardiovascular dysfunction and its association with outcome in patients with acute pancreatitis. Indian J Gastroenterol 2018; 37(2):113–119.
22 22 de‐Madaria E, Banks PA, Moya‐Hoyo N, et al. Early factors associated with fluid sequestration and outcomes of patients with acute pancreatitis. Clin Gastroenterol Hepatol 2014; 12(6):997–1002.
23 23 Whitcomb DC, Muddana V, Langmead CJ, et al. Angiopoietin‐2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. Am J Gastroenterol 2010; 105(10):2287–2292.
24 24 Bortolotti P, Saulnier F, Colling D, et al. New tools for optimizing fluid resuscitation in acute pancreatitis. World J Gastroenterol 2014; 20(43):16113–16122.
25 25 de‐Madaria E, Garg PK. Fluid therapy in acute pancreatitis: aggressive or adequate? Time for reappraisal. Pancreatology 2014; 14(6):433–435.
26 26 Mao EQ, Tang YQ, Fei J, et al. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J (Engl) 2009; 122(2):169–173.
27 27 Mao EQ, Fei J, Peng YB, et al. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin Med J (Engl) 2010; 123(13):1639–1644.
28 28 Wu BU, Hwang JQ, Gardner TH, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol 2011; 9(8):710–717.e1.
29 29 de‐Madaria E, Herrera‐Marante I, Gonzalez‐Camacho V, et al. Fluid resuscitation with lactated Ringer’s solution vs normal saline in acute pancreatitis: a triple‐blind, randomized, controlled trial. United Eur Gastroenterol J 2018; 6(1):63–72.
30 30 Buxbaum JL, Quezada M, Da B, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol 2017; 112(5):797–803.
31 31 Sun Y, Lu ZH, Zhang XS, et al. The effects of fluid resuscitation according to PiCCO on the early stage of severe acute pancreatitis. Pancreatology 2015; 15(5):497–502.
32 32 Ochagavia A, Baigorri F, Mesquida J, et al. [Hemodynamic monitoring in the critically patient. Recomendations of the Cardiological Intensive Care and CPR Working Group of the Spanish Society of Intensive Care and Coronary Units]. Med Intensiva 2014; 38(3):154–169.
33 33 Dong LH, Liu ZM, Wang SJ, et al. Corticosteroid therapy for severe acute pancreatitis: a meta‐analysis of randomized, controlled trials. Int J Clin Exp Pathol 2015; 8(7):7654–7660.
34 34 Devani K, Charilaou P, Radadiya D, et al. Acute pancreatitis: trends in outcomes and the role of acute kidney injury in mortality. A propensity‐matched analysis. Pancreatology 2018; 18(8):870–877.
35 35 Zubia‐Olaskoaga F, Maravi‐Poma E, Urreta‐Barallobre I, et al. Development and validation of a multivariate prediction model for patients with acute pancreatitis in intensive care medicine. Pancreatology 2018; 18(2):161–167.
36 36 Gougol A, Dugum M, Dudekula A, et al. Clinical outcomes of isolated renal failure compared to other forms of organ failure in patients with severe acute pancreatitis. World J Gastroenterol 2017; 23(29):5431–5437.
37 37 Mao W, Wu J, Zhang H, et al. Increase in serum chloride and chloride exposure are associated with acute kidney injury in moderately severe and severe acute pancreatitis patients. Pancreatology 2019; 19(1):136–142.
38 38 Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal‐replacement therapy in critically ill patients. N Engl J Med 2009; 361(17):1627–1638.
39 39 Palevsky PM. Indications and timing of renal replacement therapy in acute kidney injury. Crit Care Med 2008; 36(4 Suppl):S224–S228.
40 40 Schiffl H. Timing of renal replacement therapy in acute kidney injury: shedding new light on an old controversy. Indian J Crit Care Med 2018; 22(10):730–732.
41 41 Chu LP, Zhou JJ, Yu YF, et al. Clinical effects of pulse high‐volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. Ther Apher Dial 2013; 17(1):78–83.
42 42 Liu C, Li M, Cao S, et al. Effects of HV‐CRRT on PCT, TNF‐alpha, IL‐4, IL‐6, IL‐8 and IL‐10 in patients with pancreatitis complicated by acute renal failure. Exp Ther Med 2017; 14(4):3093–3097.
43 43 Hu Y, Xiong W, Li C, Cui Y. Continuous blood purification for severe acute pancreatitis: a systematic review and meta‐analysis. Medicine (Baltimore) 2019; 98(12):e14873.
44 44 Sennello JA, Fayad R, Pini M, et al. Interleukin‐18, together with interleukin‐12, induces severe acute pancreatitis in obese but not in nonobese leptin‐deficient mice. Proc Natl Acad Sci USA 2008; 105(23):8085–8090.
45 45 Ranson JH, Rifkind KM, Roses DF, et al. Objective early identification of severe acute pancreatitis. Am J Gastroenterol 1974; 61(6):443–451.
46 46 Ahmed A, Azim A, Gurjar M, Baronia AK. Hypocalcemia in acute pancreatitis revisited. Indian J Crit Care Med 2016; 20(3):173–177.
47 47 Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009; 145(1):24–33.
48 48 Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013; 11(4):761–767.
49 49 Hamada S, Masamune A, Kikuta K, Shimosegawa T. Disseminated intravascular coagulation on admission predicts complications and poor prognosis of acute pancreatitis: analysis of the nationwide epidemiological survey in Japan. Pancreas 2017; 46(2):e15–e16.
50 50 Zhan XB, Guo XR, Yang J, et al. Prevalence and risk factors for clinically significant upper gastrointestinal bleeding in patients with severe acute pancreatitis. J Dig Dis 2015; 16(1):37–42.
51 51 Shen HN, Lu CL, Li CY. The effect of gastrointestinal bleeding on outcomes of patients with acute pancreatitis: a national population‐based study. Pancreatology 2012; 12(4):331–336.
52 52 Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43(3):304–377.
53 53 Zhang XP, Tian H. Pathogenesis of pancreatic encephalopathy in severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2007; 6(2):134–140.
54 54 Compagnone C, Bellantonio D, Pavan F, et al. Posterior reversible encephalopathy syndrome in acute pancreatitis. Minerva Anestesiol 2016; 82(11):1236–1237.
55 55 Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010; 85(5):427–432.
56 56 Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra‐abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 2013; 39(7):1190–1206.
57 57 Radenkovic DV, Johnson CD, Milic N, et al. Interventional treatment of abdominal compartment syndrome during severe acute pancreatitis: current status and historical perspective. Gastroenterol Res Pract 2016; 2016:5251806.
58 58 Sun ZX, Huang HR, Zhou H. Indwelling catheter